Evaluation of Serum MicroRNAs (miR-9-5p, miR-17-5p, and miR-148a-3p) as Potential Biomarkers of Breast Cancer

Table 2

Clinicopathological characteristics of breast cancer patients.

	(%)
Tumor size (mm)
Histology
IDC	40 (81.6)
ILC	2 (4.1)
Others	7 (14.3)
ER status
+	30 (61.2)
-	19 (38.8)
PR status
+	28 (57.1)
-	21 (42.9)
HER2 status
+	35 (71.4)
-	14 (28.6)

Abbreviations: ER: estrogen receptor; IDC: invasive ductal carcinoma; HER2: human epidermal growth factor receptor 2; ILC: invasive lobular carcinoma; PR: progesterone receptor.